New therapies for hepatitis C

被引：22

作者：

Modi, Apurva A. ^{[1
]}

Hoofnagle, Jay H. ^{[1
]}

机构：

[1] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA

来源：

HEPATOLOGY | 2007年 / 46卷 / 03期

关键词：

D O I：

10.1002/hep.21892

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：615 / 617

页数：3

共 22 条

[1] Valopicitabine (NM283), alone or with peginterferon, compared to peg interferon/ribavirin (pegIFN/RBV) retreatment in patients with HCV-1 infection and prior non-response to pegIFN/RBV: One-year results [J].

Afdhal, N. ;

O'Brien, C. ;

Godofsky, E. ;

Rodriguez-Torres, M. ;

Pappas, S. C. ;

Lawitz, E. ;

Pockros, P. ;

Sulkowski, M. ;

Jacobson, I. ;

Chao, G. ;

Knox, S. ;

Pietropaolo, K. ;

Brown, N. A. .

JOURNAL OF HEPATOLOGY, 2007, 46 :S5-S5

[2] Ascending multiple-dose pharmacokinetics of viramidine, a prodrug of ribavirin, in adult subjects with compensated hepatitis C infection [J].

Aora, S ;

Xu, C ;

Teng, A ;

Peterson, J ;

Yeh, LT ;

Gish, R ;

Lou, D ;

Rossi, S ;

Lin, C .

JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (03) :275-285

[3] A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients [J].

Bain, VG ;

Kaita, KD ;

Yoshida, EM ;

Swain, MG ;

Heathcote, EJ ;

Neumann, AU ;

Fiscella, M ;

Yu, R ;

Osborn, BL ;

Cronin, PW ;

Freimuth, WW ;

McHutchison, JG ;

Subramanian, GM .

JOURNAL OF HEPATOLOGY, 2006, 44 (04) :671-678

[4] NONSTRUCTURAL PROTEIN-3 OF THE HEPATITIS-C VIRUS ENCODES A SERINE-TYPE PROTEINASE REQUIRED FOR CLEAVAGE AT THE NS3/4 AND NS4/5 JUNCTIONS [J].

BARTENSCHLAGER, R ;

AHLBORNLAAKE, L ;

MOUS, J ;

JACOBSEN, H .

JOURNAL OF VIROLOGY, 1993, 67 (07) :3835-3844

[5]

FORESTIER N, 2007, HEPATOLOGY, V46

[6] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].

Fried, MW ;

Shiffman, ML ;

Reddy, KR ;

Smith, C ;

Marinos, G ;

Goncales, FL ;

Haussinger, D ;

Diago, M ;

Carosi, G ;

Dhumeaux, D ;

Craxi, A ;

Lin, A ;

Hoffman, J ;

Yu, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982

[7] Peginterferon and ribavirin for chronic hepatitis C [J].

Hoofnagle, Jay H. ;

Seeff, Leonard B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2444-2451

[8]

KIEFFER T, 2007, HEPATOLOGY, V46

[9] An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus [J].

Lamarre, D ;

Anderson, PC ;

Bailey, M ;

Beaulieu, P ;

Bolger, G ;

Bonneau, P ;

Bös, M ;

Cameron, DR ;

Cartier, M ;

Cordingley, MG ;

Faucher, AM ;

Goudreau, N ;

Kawai, SH ;

Kukolj, G ;

Lagacé, L ;

LaPlante, SR ;

Narjes, H ;

Poupart, MA ;

Rancourt, J ;

Sentjens, RE ;

St George, R ;

Simoneau, B ;

Steinmann, G ;

Thibeault, D ;

Tsantrizos, YS ;

Weldon, SM ;

Yong, CL ;

Llinàs-Brunet, M .

NATURE, 2003, 426 (6963) :186-189

[10] Clearance of HCV RNA with valopicitabine (NM283) plus peg-interferon in treatment-naive patients with HCV-1 infection: Results at 24 and 48 weeks [J].

Lawitz, E. ;

Nguyen, T. ;

Younes, Z. ;

Santoro, J. ;

Gitlin, N. ;

McEniry, D. ;

Chasen, R. ;

Goff, J. ;

Dieterich, D. ;

Knox, S. ;

Kleber, K. ;

Belanger, B. ;

Brown, N. A. ;

Grp, Investigator .

JOURNAL OF HEPATOLOGY, 2007, 46 :S9-S9

← 1 2 3 →